"All GLP-1 attorneys are the same" Far from it
Amylyxs targeting of the GLP-1 space follows the companys decision to pull its ALS drug Relyvrio off the shelves earlier this year and to axe around 70% of its workforce under a restructuring plan
Besides, hypertension, hyperlipidemia, cardiovascular disease, COPD, gastroesophageal reflux disease, somnolence, and stroke are not significant (Table 3)
my meds are delivered on time, and book me automatically to have a Dr contact me to renew my prescriptions
For detailed side effect management strategies that apply to all GLP-1 medications, see our pharmacists semaglutide side effects timeline most of the same management strategies apply to orforglipron
From what I've seen, semaglutide beats out the other GLP-1s pretty consistently - you're looking at about 2-3% better weight loss vs liraglutide or dulaglutide